• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺纤维化患者睡眠和运动期间的呼吸紊乱及生物标志物的作用。

Disordered breathing during sleep and exercise in idiopathic pulmonary fibrosis and the role of biomarkers.

机构信息

From the Department of Respiratory Medicine, St. Vincent's University Hospital, School of Medicine and Medical Science, University College Dublin, Department of Radiology, St. Vincent's University Hospital, Dublin, Ireland From the Department of Respiratory Medicine, St. Vincent's University Hospital, School of Medicine and Medical Science, University College Dublin, Department of Radiology, St. Vincent's University Hospital, Dublin, Ireland.

From the Department of Respiratory Medicine, St. Vincent's University Hospital, School of Medicine and Medical Science, University College Dublin, Department of Radiology, St. Vincent's University Hospital, Dublin, Ireland.

出版信息

QJM. 2015 Apr;108(4):315-23. doi: 10.1093/qjmed/hcu175. Epub 2014 Sep 23.

DOI:10.1093/qjmed/hcu175
PMID:25253897
Abstract

BACKGROUND AND OBJECTIVE

Idiopathic pulmonary fibrosis (IPF) patients report fatigue, possibly reflecting sleep disturbance, but little is known about sleep-related changes. We compared ventilation and gas exchange during sleep and exercise in a cohort of IPF patients, and evaluated associations with selected biological markers.

METHODS

Twenty stable IPF patients (aged 67.9 ± 12.3 [SD]) underwent overnight polysomnography following an acclimatization night. Cardiopulmonary exercise testing was performed and inflammatory markers measured including TNF-α, IL-6, CXCL8, C-C motif ligand 18 (CCL-18) and C-reactive protein (CRP) RESULTS: Nine patients had sleep-disordered breathing (SDB) with an apnea-hypopnea frequency (AHI) ≥ 5/h, but only two had Epworth sleepiness score ≥ 10, thus having an obstructive sleep apnea syndrome. Sleep quality was poor. Transcutaneous carbon dioxide tension (PtcCO2) rose by 2.56 ± 1.59 kPa overnight (P = 0.001), suggesting hypoventilation. Oxygen saturation (SaO2) was lower during sleep than exercise (P < 0.01), and exercise variables correlated with resting pulmonary function. CCL-18 and CRP levels were elevated and correlated with PtcCO2 rise during sleep (P < 0.05). CCL-18 negatively correlated with diffusion capacity of carbon monoxide (DLCO), arterial oxygen (PaO2) and mean arterial carbon dioxide (PaCO2) (P < 0.05) and CRP negatively correlated with DLCO, PaO2, sleep SaO2 and oxygen uptake (VO2) during exercise (P < 0.05).

CONCLUSIONS

IPF patients desaturate more during sleep than exercise; thus, nocturnal pulse oxymetry could be included in clinical assessment. CCL-18 and CRP levels correlate with physiological markers of fibrosis.

摘要

背景与目的

特发性肺纤维化(IPF)患者报告疲劳,可能反映了睡眠障碍,但对于与睡眠相关的变化知之甚少。我们比较了一组 IPF 患者的睡眠和运动期间的通气和气体交换,并评估了与选定生物标志物的关联。

方法

20 名稳定的 IPF 患者(年龄 67.9 ± 12.3[SD])在适应过夜后进行了整夜多导睡眠图检查。进行了心肺运动测试,并测量了炎症标志物,包括 TNF-α、IL-6、CXCL8、C 型趋化因子配体 18(CCL-18)和 C 反应蛋白(CRP)。

结果

9 名患者有睡眠呼吸障碍(SDB),呼吸暂停低通气指数(AHI)≥5/小时,但只有 2 名患者的嗜睡评分≥10,因此患有阻塞性睡眠呼吸暂停综合征。睡眠质量差。夜间经皮二氧化碳分压(PtcCO2)升高 2.56 ± 1.59 kPa(P=0.001),提示通气不足。睡眠时的血氧饱和度(SaO2)低于运动时(P<0.01),并且运动变量与静息肺功能相关。CCL-18 和 CRP 水平升高,并与睡眠期间 PtcCO2 升高相关(P<0.05)。CCL-18 与一氧化碳弥散量(DLCO)、动脉血氧(PaO2)和平均动脉二氧化碳(PaCO2)呈负相关(P<0.05),CRP 与 DLCO、PaO2、睡眠时 SaO2 和摄氧量(VO2)呈负相关在运动期间(P<0.05)。

结论

与运动相比,IPF 患者在睡眠期间饱和度下降更多;因此,夜间脉搏血氧仪可以包含在临床评估中。CCL-18 和 CRP 水平与纤维化的生理标志物相关。

相似文献

1
Disordered breathing during sleep and exercise in idiopathic pulmonary fibrosis and the role of biomarkers.特发性肺纤维化患者睡眠和运动期间的呼吸紊乱及生物标志物的作用。
QJM. 2015 Apr;108(4):315-23. doi: 10.1093/qjmed/hcu175. Epub 2014 Sep 23.
2
Treating sleep-disordered breathing of idiopathic pulmonary fibrosis patients with CPAP and nocturnal oxygen treatment. A pilot study : Sleep-disordered breathing treatment in IPF.特发性肺纤维化患者使用 CPAP 和夜间氧疗治疗睡眠呼吸障碍:一项初步研究:IPF 中的睡眠呼吸障碍治疗。
Respir Res. 2024 Jun 18;25(1):247. doi: 10.1186/s12931-024-02871-6.
3
How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis?特发性肺纤维化患者睡眠呼吸障碍的发生率有多高?
Sleep Breath. 2010 Dec;14(4):387-90. doi: 10.1007/s11325-010-0336-5. Epub 2010 Mar 16.
4
Quality of life in idiopathic pulmonary fibrosis: The impact of sleep disordered breathing.特发性肺纤维化患者的生活质量:睡眠呼吸障碍的影响。
Respir Med. 2019 Feb;147:51-57. doi: 10.1016/j.rmed.2018.12.018. Epub 2019 Jan 10.
5
Sleep and breathing in idiopathic pulmonary fibrosis.特发性肺纤维化中的睡眠和呼吸。
J Physiol Pharmacol. 2009 Nov;60 Suppl 5:13-4.
6
Sleep-disordered breathing with nighttime hypocapnia relates to daytime enhanced ventilatory response to exercise in patients with heart disease.患有睡眠呼吸障碍合并夜间低碳酸血症与心脏病患者白天运动时增强的通气反应有关。
J Nippon Med Sch. 2012;79(6):409-15. doi: 10.1272/jnms.79.409.
7
Screening Strategies for Sleep-Disordered Breathing in Patients With Spinal Cord Injury in a Tertiary Care Rehabilitation Center.三级康复中心脊髓损伤患者睡眠呼吸障碍的筛查策略。
Respir Care. 2024 Aug 24;69(9):1116-1128. doi: 10.4187/respcare.11726.
8
Sleep hypoventilation and daytime hypercapnia in stable chronic obstructive pulmonary disease.稳定期慢性阻塞性肺疾病患者的睡眠通气不足和日间高碳酸血症。
Int J Chron Obstruct Pulmon Dis. 2014 Feb 27;9:265-75. doi: 10.2147/COPD.S57576. eCollection 2014.
9
Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis.特发性肺纤维化患者的睡眠氧减预测生存。
J Clin Sleep Med. 2013 Jun 15;9(6):593-601. doi: 10.5664/jcsm.2758.
10
Nocturnal assisted ventilation using bilevel positive airway pressure: the effect of expiratory positive airway pressure.采用双水平气道正压进行夜间辅助通气:呼气末正压的作用
Eur Respir J. 1995 Mar;8(3):436-40. doi: 10.1183/09031936.95.08030436.

引用本文的文献

1
The Link Between Sleep-Related Breathing Disorders and Idiopathic Pulmonary Fibrosis: Pathophysiological Mechanisms and Treatment Options-A Review.睡眠相关呼吸障碍与特发性肺纤维化之间的联系:病理生理机制与治疗选择——综述
J Clin Med. 2025 Mar 24;14(7):2205. doi: 10.3390/jcm14072205.
2
The Chemokine System as a Key Regulator of Pulmonary Fibrosis: Converging Pathways in Human Idiopathic Pulmonary Fibrosis (IPF) and the Bleomycin-Induced Lung Fibrosis Model in Mice.趋化因子系统作为肺纤维化的关键调节因子:人类特发性肺纤维化(IPF)与博来霉素诱导的小鼠肺纤维化模型中的共同通路
Cells. 2024 Dec 12;13(24):2058. doi: 10.3390/cells13242058.
3
Treating sleep-disordered breathing of idiopathic pulmonary fibrosis patients with CPAP and nocturnal oxygen treatment. A pilot study : Sleep-disordered breathing treatment in IPF.
特发性肺纤维化患者使用 CPAP 和夜间氧疗治疗睡眠呼吸障碍:一项初步研究:IPF 中的睡眠呼吸障碍治疗。
Respir Res. 2024 Jun 18;25(1):247. doi: 10.1186/s12931-024-02871-6.
4
Influence of Impaired Diffusing Capacity and Sleep-disordered Breathing on Nocturnal Hypoxemia and Health Outcomes in Men with and without Human Immunodeficiency Virus.在有和没有人类免疫缺陷病毒的男性中,弥散功能障碍和睡眠呼吸障碍对夜间低氧血症和健康结果的影响。
Ann Am Thorac Soc. 2024 Jul;21(7):1085-1093. doi: 10.1513/AnnalsATS.202309-757OC.
5
The Association between Idiopathic Pulmonary Fibrosis and Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis.特发性肺纤维化与阻塞性睡眠呼吸暂停之间的关联:一项系统评价与荟萃分析
J Clin Med. 2022 Aug 26;11(17):5008. doi: 10.3390/jcm11175008.
6
Management of Progressive Fibrosing Interstitial Lung Diseases (PF-ILD).进行性纤维化间质性肺疾病(PF-ILD)的管理
Front Med (Lausanne). 2021 Oct 13;8:743977. doi: 10.3389/fmed.2021.743977. eCollection 2021.
7
Prevalence and impact of comorbid obstructive sleep apnoea in diffuse parenchymal lung diseases.弥漫性实质性肺疾病中合并阻塞性睡眠呼吸暂停的患病率和影响。
PLoS One. 2021 Feb 11;16(2):e0246878. doi: 10.1371/journal.pone.0246878. eCollection 2021.
8
Proteomic biomarkers of sleep apnea.睡眠呼吸暂停的蛋白质组学生物标志物。
Sleep. 2020 Nov 12;43(11). doi: 10.1093/sleep/zsaa086.
9
The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases.高迁移率族蛋白 B1(HMGB1)作为一种核损伤相关分子模式分子,在肺部疾病发病机制中的作用。
Antioxid Redox Signal. 2019 Nov 1;31(13):954-993. doi: 10.1089/ars.2019.7818. Epub 2019 Jul 11.
10
Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night.特发性肺纤维化与睡眠障碍:不再是夜间的陌生人。
Eur Respir Rev. 2015 Jun;24(136):327-39. doi: 10.1183/16000617.00009114.